Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio
08:00am, Thursday, 06'th Apr 2023
CRISPR Therapeutics and Bluebird Bio will soon likely compete for market share. CRISPR has plenty of money and a collaborator with deep pockets.
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
12:15am, Thursday, 06'th Apr 2023
Cathie Wood-led ARK Investment Management raised stakes in a number of biotech companies on Wednesday with these stocks recording negative returns over the last one month, potentially making them attr
2 Under-the-Radar Biotech Stocks to Buy in 2023
10:11am, Wednesday, 05'th Apr 2023
CRISPR Therapeutics' near-term outlook is quite bullish. There are more lucrative opportunities for Exelixis in the near future.
CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel
03:14pm, Tuesday, 04'th Apr 2023
CRISPR (CRSP) and Vertex complete BLA submissions to the FDA for exa-cel for treating sickle cell disease and transfusion-dependent beta-thalassemia.
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
02:00pm, Tuesday, 04'th Apr 2023
Vertex Pharmaceuticals is a top seller of cystic fibrosis treatments -- but it's about to expand into a new growth area. Vertex and partner CRISPR Therapeutics have just completed the submission of th
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
05:30am, Saturday, 01'st Apr 2023
Vertex Pharmaceuticals is licensing CRISPR's technology for its type 1 diabetes program. The deal involves an up-front payment, milestone payments -- and the potential for royalties down the road.
5 Bargain-Basement Stocks to Buy Right Now
05:30am, Friday, 31'st Mar 2023
These stocks all have suffered in recent times, but the long-term growth picture remains bright for each one. Buying on the dip and holding for at least five years is a great way to benefit.
Buy Crispr Therapeutics On Approval Odds
04:07am, Friday, 31'st Mar 2023
CTX001 has progressed enough to start discussing details regarding the launch of the program. Regulatory decisions, likely carrying an approval, will likely come in the coming quarters.
The 3 Best Growth Stocks to Buy in the Biotech Sector
10:23pm, Wednesday, 29'th Mar 2023
Investors may want to keep an eye on biotech growth stocks, which are typically associated with the risk-on trade. Case in point: The sector ran up in January, but when the broader-market rally fizzle
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
08:54pm, Wednesday, 29'th Mar 2023
While it's a common conspiracy theory – and comedic punchline – that medical innovators only seek to manage problems rather than cure them, the reality is that several biotech stocks to buy underg
Could CRISPR Therapeutics Become the Next Moderna?
06:00am, Monday, 27'th Mar 2023
CRISPR has some important elements in common with vaccine giant Moderna. And the company is heading for an important moment in its growth story.
Could This Stock Become the Tesla of Its Industry?
09:30am, Saturday, 25'th Mar 2023
CRISPR's gene editing process could change how we treat disease. The biotech's first potential product, exa-cel, could soon hit the market.
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
09:17am, Saturday, 25'th Mar 2023
CRISPR could revolutionize the way we treat thousands of diseases. Currently, there are about 7,000 caused by genetic disorders, which occur when a mutation affects your genes, or when you have the wr
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
This Cathie Wood Stock Could Nearly Double, According to Wall Street
10:07am, Thursday, 23'rd Mar 2023
CRISPR Therapeutics is closing in on an important regulatory event. The FDA is considering its potential gene-editing therapy for sickle cell disease.
